These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 23392570)

  • 1. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
    Hilakivi-Clarke L; de Assis S; Warri A
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):25-42. PubMed ID: 23392570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer.
    Paulose T; Speroni L; Sonnenschein C; Soto AM
    Reprod Toxicol; 2015 Jul; 54():58-65. PubMed ID: 25277313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating chemical effects on mammary gland development: A critical need in disease prevention.
    Osborne G; Rudel R; Schwarzman M
    Reprod Toxicol; 2015 Jul; 54():148-55. PubMed ID: 25091782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental exposures, breast development and cancer risk: Through the looking glass of breast cancer prevention.
    Forman MR; Winn DM; Collman GW; Rizzo J; Birnbaum LS
    Reprod Toxicol; 2015 Jul; 54():6-10. PubMed ID: 25499721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of dietary estrogenic exposures and breast cancer risk.
    De Assis S; Hilakivi-Clarke L
    Ann N Y Acad Sci; 2006 Nov; 1089():14-35. PubMed ID: 17261753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.
    Teitelbaum SL; Belpoggi F; Reinlib L
    Reprod Toxicol; 2015 Jul; 54():141-7. PubMed ID: 25549947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters.
    Hilakivi-Clarke L
    Breast Cancer Res; 2014; 16(2):208. PubMed ID: 25032259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic estrogen as a endocrine disruptor--diethylstilbestrol and oral contraceptives].
    Takai Y; Tsutsumi O
    Nihon Rinsho; 2000 Dec; 58(12):2409-16. PubMed ID: 11187729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy.
    Titus-Ernstoff L; Hatch EE; Hoover RN; Palmer J; Greenberg ER; Ricker W; Kaufman R; Noller K; Herbst AL; Colton T; Hartge P
    Br J Cancer; 2001 Jan; 84(1):126-33. PubMed ID: 11139327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional modulation of terminal end buds: its relevance to breast cancer prevention.
    Hilakivi-Clarke L
    Curr Cancer Drug Targets; 2007 Aug; 7(5):465-74. PubMed ID: 17691906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine-active chemicals in mammary cancer causation and prevention.
    Jenkins S; Betancourt AM; Wang J; Lamartiniere CA
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estetrol and Mammary Gland: Friends or Foes?
    Gallez A; Dias Da Silva I; Wuidar V; Foidart JM; Péqueux C
    J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):297-308. PubMed ID: 34463898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.
    Doherty LF; Bromer JG; Zhou Y; Aldad TS; Taylor HS
    Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous hormones in the aetiology of cancer in women.
    Vessey MP
    J R Soc Med; 1984 Jul; 77(7):542-9. PubMed ID: 6379176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disruptors and the breast: early life effects and later life disease.
    Macon MB; Fenton SE
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):43-61. PubMed ID: 23417729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
    Herbst AL
    Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Exposure to Diethylstilbestrol During Pregnancy With Multigenerational Neurodevelopmental Deficits.
    Kioumourtzoglou MA; Coull BA; O'Reilly ÉJ; Ascherio A; Weisskopf MG
    JAMA Pediatr; 2018 Jul; 172(7):670-677. PubMed ID: 29799929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heritable legacy of diethylstilbestrol: a bellwether for endocrine disruption in humans.
    Robotti S
    Biol Reprod; 2021 Sep; 105(3):687-689. PubMed ID: 34402505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.